Research
Hormonal
Pharmacological activation of AMPK by metformin improves insulin sensitivity and reduces the incidence of type 2 diabetes and cardiovascular events.
If you have type 2 diabetes or are at high risk, discuss metformin with your doctor. It is a widely used medication that helps improve insulin sensitivity and may reduce your risk of heart disease and other complications.
GoodSupportsHIGH confidence
Metformin, a widely used antidiabetic drug that modestly increases insulin sensitivity, was reported to act as an AMPK activator... metformin use was associated with a significant decrease in the incidence of myocardial infarction and a 36% decrease in all-cause mortality.
Why this rating
Supported by clinical trials showing reduced mortality and diabetes incidence, though some mechanisms are AMPK-independent.
Source
AMPK, insulin resistance, and the metabolic syndrome
Neil B. Ruderman et al. · Journal of Clinical Investigation · 2013
DOI 10.1172/jci67227
narrative_reviewCited 860×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Regular exercise and calorie restriction improve insulin sensitivity and reduce the prevalence of metabolic syndrome-associated diseases by activating AMP-activated protein kinase (AMPK).Good
- Dysregulation of AMPK activity is associated with insulin resistance and the metabolic syndrome in humans.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →